Riparian Pharmaceuticals

Riparian Pharmaceuticals is a privately held biotechnology company established to discover drug targets and therapeutic approaches that impact endothelial dysfunction and vascular inflammation. These two processes are fundamental to and drivers of several cardiometabolic diseases.